Immune response to lower urinary tract infections


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Urinary tract infections are one of the most common and widespread infectious diseases. A certain role in etiopathogenesis may play genetic predisposition, as well as a decrease in antiadhesive properties and an increase in urothelium permeability due to incompetence of bladder glycosaminoglycan layer. The prevalence of infectious diseases increases significantly with age, as well as in patients with chronic diseases. The introduction of modern biotechnology has allowed clinicians to greatly expand therapeutic armamentarium, while having a number of advantages, including minimal frequency of complications and adverse events, the possibility for long-term use, accessibility, and etc. Priority research areas include the study of toll-like receptors, which are transmembrane proteins that provide pathogen recognition and activate the immune response. The role of these receptors in the development of the immune response to urinary tract infections was evaluated in our study, which allows to predict the course of the disease and to increase treatment efficiency.

Full Text

Restricted Access

About the authors

A. O Vasil'ev

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: alexvasilyev@me.com

A. V Zaycev

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: zaitcevandrew@mail.ru

A. A Shiryaev

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: phd.shiryaev@gmail.com

E. A Prilepskaya

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: prilepskayae@mail.ru

Yu. A Kim

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: dockimyura@gmail.com

N. A Kalinina

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: kalininatalia06@gmail.com

D. Yu Pushkar

A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia

Email: pushkardm@mail.ru

References

  1. Anderson G.G., Palermo J.J., Schilling J.D. et al. Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections. Science J. 2003; 301(5629):105-107.
  2. Ferry S.A., Holm S.E., Stenlund H. et al. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J. Inf Dis. 2004;36:296-301.
  3. Dubbs S.B., Sommerkamp S.K. Evaluation and Management of Urinary Tract Infection in the Emergency Department. Emerg Med Clin North Am. 2019;37(4):707-723.
  4. Симбирцев А.С. Толл-белки: специфические рецепторы неспецифического) иммунитета. Иммунология. 2005;26(6):368-376.
  5. Werling D., Jungi T.W. TLR liking innate and adaptive immune response. Vet. Immunol. Immunopathol. 2003;91: 1-12.
  6. Джанеуэй Ч., Меджитов Р. Понятие о распознавании паттернов (образов) патогенности.
  7. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F. et al. Recognition of commensal microflora by TLRs is required for intestinal homeostasis. Cell. 2004;118:229-241.
  8. Sellers D.J., McDermott C., Chess-Williams R. A central role for Tolllike 4 receptors in interstitial cystitis? Am J. Physiol Renal Physiol. 2018;315(4):F910-F912.
  9. Ching C.B., Gupta S., Li B. et al. Interleukin-6/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection. Kidney Int. 2018;93(6):1320-1329.
  10. Gorski A., Dqbrowska K., Miqdzybrodzki R. et al. Phages and immunomodulation. Future Microbiol. 2017;12:905-914.
  11. Gorski A., Miqdzybrodzki R., Weber Dqbrowska B. et al. Phage therapy: combating infections with potential for evolving from merely a treatment for complications to tageting diseases. Front Microbiol 2016;7:1515.
  12. Barr J.J., Auro R., Furlan M. et al. Bacteriophage adhering to mucus provide a non host derived immunity. Proc Nat Acad Sci USA 2013;110:10771-10776.
  13. Li D., Hu S., Fan Q., Bao W. et al. Phage display screening of TIGIT-specific antibody for antitumor immunotherapy Biosci Biotechnol Biochem. 2019;83(9):1683-1696.
  14. Zhao A., Tohidkia M.R., Siegel D.L. et al. Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy. Crit Rev Biotechnol. 2016;36(2):276-289.
  15. Roach D.R., Leung C.Y., Henry M. et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 2017; 22:38-47.
  16. Borysowski J., Miqdzybrodzki R., Wierzbicki P. et al. A3R phage and Staphylococcus aureus lysate do not induce neutrophil degranulation. Viruses. 2017;9:E36.
  17. Sinha A., Maurice C.F. Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System. Mediators Inflamm. 2019;2019:3730519.
  18. Shrivastava S., Shrivastava P., Ramasamy J. World Health Organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J. Med. Soc. 2018;32:76-77.
  19. Sweere J.M., Van Belleghem J.D., Ishak H. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363(6434):eaat9691.
  20. Secor P.R., Michaels L.A., Smigiel K.S. et al. Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo. Infect Immun. 2016;85(1):e00648-16.
  21. Makarova K.S., Haft D.H., Barrangou R. et al. Evolution and classification of the CRISPR-Cas systems. Nature reviews. Microbiology. 2011;9(6):467-477.
  22. Barrangou R. Diversity of CRISPR-Cas immune systems and molecular machines. Genome Biol. 2015;16:247.
  23. Seed K.D., Lazinski D.W., Calderwood S.B., Camilli A. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature. 2013;494(7438):489-491.
  24. Коровкина Е.С., Кажарова С.В. Роль toll-подобных рецепторов в патогенезе воспалительных заболеваний бронхолегочной системы. Инфекция и иммунитет. 2016;6(2):109-116
  25. Толстопятова М.А., Буслаева Г.А., Козлов И.Г. Роль рецепторов врожденного иммунитета в развитии инфекционной патологии и новорожденных детей. Педиатрия. Журнал им. Г.Н. Сперанского. 2009;87(1):115-120

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies